A polymorphism in the 3 '-untranslated region of the NPM1 gene causes illegitimate regulation by microRNA-337-5p and correlates with adverse outcome in acute myeloid leukemia
Publication in refereed journal

Times Cited
Web of Science10WOS source URL (as at 20/09/2020) Click here for the latest count
Altmetrics Information

Other information
AbstractNucleophosmin, encoded by NPM1, is a haploinsufficient suppressor in hematologic malignancies. NPM1 mutations are mostly found in acute myeloid leukemia patients with normal karyotype and associated with favorable prognosis. A polymorphic nucleotide T deletion with unknown significance is present in the NPM1 3'-untranslated region. Here, we showed that the homozygous nucleotide T deletion was associated with adverse outcomes and could independently predict shortened survival in patients with de novo acute myeloid leukemia. Mechanistically, we demonstrated that the nucleotide T deletion created an illegitimate binding NPM1 for miR-337-5p, which was widely expressed in different acute myeloid leukemia subtypes and inhibited NPM1 expression. Accordingly, NPM1 levels were found to be significantly reduced and correlated with miR-337-5p levels in patients carrying a homozygous nucleotide T-deletion genotype. Together, our findings uncover a microRNA-mediated control of NPM1 expression that contributes to disease heterogeneity and suggest additional prognostic values of NPM1 in acute myeloid leukemia.
All Author(s) ListCheng CK, Kwan TK, Cheung CY, Ng K, Liang P, Cheng SH, Chan NPH, Ip RKL, Wong RSM, Lee V, Li CK, Yip SF, Ng MHL
Journal nameHaematologica
Volume Number98
Issue Number6
Pages913 - 917
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesHematology

Last updated on 2020-21-09 at 00:52